ARWR:NASDAQ
Arrowhead Pharmaceuticals Inc
$61.54
arrow_downward
-1.30%(-0.81) 1D
$61.54
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 6, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARWR...
Open
$62.86
High
$63.18
Low
$60.56
Mkt. cap
8.95B
Avg. vol.
2.00M
Volume
1.68M
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
Open
$62.86
High
$63.18
Low
$60.56
Mkt. cap
8.95B
Avg. vol.
2.00M
Volume
1.68M
52-wk high
$95.49
52-wk low
$34.61
EPS
-$2.24
Beta
1.30
Shares outstanding
141.25M
No. of employees
711
News stories
From web sources and news partners
Washington Times
·
22 minutes ago
Wall Street profits surge as inflation and card debt stay elevated
Fox News
·
51 minutes ago
Fox News Media CEO Suzanne Scott rings Nasdaq closing bell in honor of network's 30th anniversary
PR Newswire
·
12 minutes ago
QuickLogic Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Profile
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead's products in development act through RNA interference mechanisms of action. The company focuses on treatments for hepatitis B, liver disease associated with alpha 1-antitrypsin deficiency and cardiovascular disease. Wikipedia
About Arrowhead Pharmaceuticals Inc
CEOChristopher Richard Anzalone
Employees711
FoundedJan 1, 2004
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitearrowheadpharma.com